Breast cancer study predicts better response to chemotherapy

It is known from previous research that the ER-beta estrogen receptor often has a protective effect. A new study from Lund University in Sweden has found that this effect is more pronounced in patients that undergo chemotherapy.

"If the finding is confirmed in further studies, it could contribute to with the highest risk getting more frequent check-ups and/or additional treatment besides , or possibly limit chemotherapy to the women in the ," says Karin Elebro, PhD student and lead author of the study.

"We have investigated an called ER-beta in tumours from close to 1000 women who underwent surgery for breast cancer between 2002 and 2012. This revealed that outcomes were better for the women in the study who had a high expression of the receptor, compared to those who had a low expression. When we examined more closely the additional treatments the women received after surgery, the was more pronounced in those who had received chemotherapy," explain Karin Elebro and Helena Jernström, researcher and associate professor in experimental oncology.

There are two main types of estrogen receptors - ER-alpha and ER-beta - both of which are present in normal cells and in cancer cells. ER-alpha is well known to researchers, whereas ER-beta has not been studied as much.

"Previous studies of estrogen receptor ER-beta have mainly focused on anti-hormonal treatment and not on chemotherapy. This is why it seems particularly valuable for the next step to be a study of women who have undergone chemotherapy. It should be possible to conduct an analysis equivalent to our study on tumours in previously conducted randomized trials in which women were given chemotherapy, in order to confirm our findings.

This is important as we currently have so few markers capable of predicting which women will benefit most from chemotherapy," says Helena Jernström.

More information: K. Elebro et al. High Estrogen Receptor Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients—Results from a Population-Based Breast Cancer Cohort, Clinical Cancer Research (2016). DOI: 10.1158/1078-0432.CCR-16-1095

Journal information: Clinical Cancer Research

Provided by Lund University
Citation: Breast cancer study predicts better response to chemotherapy (2016, December 15) retrieved 27 March 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Study indicates that advances in precision medicine have improved breast cancer treatment


Feedback to editors